Home > Animal Health & Nutrition > Veterinary Medical Devices > Pet DNA Testing Market

Pet DNA Testing Market Trends

Report ID: GMI10402
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Pet DNA Testing Market Trends

The market is witnessing robust growth, propelled by a surge in pet owners' awareness of genetic health issues. Owners are increasingly turning to online resources, veterinary advice, and media coverage to learn about hereditary conditions and the advantages of genetic testing.
Veterinarians play a crucial role in advocating for DNA tests as part of routine pet healthcare. These tests aid in the early detection and management of genetic predispositions.
Moreover, the growing trend of pet humanization is leading owners to invest more in their pets' healthcare, including advanced options. With advancements in genetic testing technology, these tests are becoming more accurate, affordable, and accessible, further fueling their adoption rates.
This collective shift towards heightened awareness and a proactive stance emphasizes the importance of understanding genetic risks, a factor that is significantly driving the expansion of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market was worth USD 351.6 million in 2023 and is poised to remarkably grow at a rate of 9% through 2032, owing to technological advancements in genetic testing, particularly in genomics.

The dogs segment held the highest market share of 72.4% in 2023 as dogs boast a wide array of breeds and genetic backgrounds, compelling owners to turn to DNA tests for a comprehensive understanding of their pets' lineage.

In 2023, North America pet DNA testing market reached a value of USD 139.2 million, with a projected CAGR of 8.9% from 2024 to 2032, backed by high rate of pet ownership, advanced veterinary care infrastructure, and a growing awareness among pet owners regarding proactive pet health management.

Ancestry, Basepaws, Inc. (Zoetis), DNA MY DOG (Canadian Dog Group Ltd.), Dognomics (Clinomics), Embark Veterinary, Inc., FidoCure (OHC), GenSolDiagnostics, LLC, Neogen Corporation, Orivet Genetic Pet Care Ltd., and Wisdom Panel (Mars, Inc.).